Physician profile
Augustus John Rush, JR.
NPI 1720040991
$759,556.26
in general payments reported to CMS, 2019-2025
9 companies · $214K in 2025
The $214K reported for 2025 was more than what 99% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102K · 2020: $76K · 2021: $47K · 2022: $65K · 2023: $75K · 2024: $182K · 2025: $214K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $439K · Consulting Fee: $24K · Honoraria: $5,200 · Travel and Lodging: $1,454 · Food and Beverage: $1,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $439,182.00 |
| Consulting Fee | $24,004.49 |
| Honoraria | $5,200.00 |
| Travel and Lodging | $1,453.79 |
| Food and Beverage | $1,032.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $607,364.68 | 2019-2025 | Vns Therapy Symmetry Model 8103 Generator, Vns Therapy Sentiva Model 1000 Generator |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $57,264.30 | 2020-2024 | Abilify Mycite |
| Janssen Research & Development, LLC | $36,300.00 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $21,007.04 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15,015.00 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $13,625.00 | 2020-2021 | |
| Highridge Medical LLC | $8,700.00 | 2024 | Vital |
| Nuvasive, INC. | $258.07 | 2021-2022 | |
| Cpm Medical Consultants, LLC | $22.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augustus Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.